{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:23:06Z","timestamp":1792819386366,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C1008613"],"award-info":[{"award-number":["2021R1A2C1008613"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003566","name":"Ministry of Oceans and Fisheries","doi-asserted-by":"publisher","award":["PM21030 (15250103)"],"award-info":[{"award-number":["PM21030 (15250103)"]}],"id":[{"id":"10.13039\/501100003566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>BRCA1-associated protein-1 (BAP1) is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase. The gene encoding BAP1 is mutated in various human cancers, including mesothelioma, uveal melanoma and renal cell carcinoma. BAP1 plays roles in many cancer-related cellular functions, including cell proliferation, cell death, and nuclear processes crucial for genome stability, such as DNA repair and replication. While these findings suggest that BAP1 functions as a tumor suppressor, recent data also suggest that BAP1 might play tumor-promoting roles in certain cancers, such as breast cancer and hematopoietic malignancies. Here, we show that BAP1 is upregulated in colon cancer cells and tissues and that BAP1 depletion reduces colon cancer cell proliferation and tumor growth. BAP1 contributes to colon cancer cell proliferation by accelerating DNA replication and suppressing replication stress and concomitant apoptosis. A recently identified BAP1 inhibitor, TG2-179-1, which seems to covalently bind to the active site of BAP1, exhibits potent cytotoxic activity against colon cancer cells, with half-maximal inhibitory concentrations of less than 10\u00a0\u03bcM, and inhibits colon tumor growth. TG2-179-1 exerts cytotoxic activity by targeting BAP1, leading to defective replication and increased apoptosis. This work therefore shows that BAP1 acts oncogenically in colon cancer and is a potential therapeutic target for this cancer. Our work also suggests that TG2-179-1 can be developed as a potential therapeutic agent for colon cancer.<\/jats:p>","DOI":"10.1038\/s41598-023-29017-w","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T16:04:19Z","timestamp":1675872259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeting BAP1 with small compound inhibitor for colon cancer treatment"],"prefix":"10.1038","volume":"13","author":[{"given":"Minhwa","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Gi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Eknath","family":"Shirbhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yeon","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Mook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Shin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongbum","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"29017_CR1","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen, D. E. et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097\u20131112 (1998).","journal-title":"Oncogene"},{"key":"29017_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone, M. et al. BAP1 and cancer. Nat. Rev. Cancer 13, 153\u2013159 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"29017_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","volume":"28","author":"L Masclef","year":"2021","unstructured":"Masclef, L. et al. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Cell Death Differ 28, 606\u2013625 (2021).","journal-title":"Cell Death Differ"},{"key":"29017_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41420-021-00406-2","volume":"7","author":"AP Szczepanski","year":"2021","unstructured":"Szczepanski, A. P. & Wang, L. Emerging multifaceted roles of BAP1 complexes in biological processes. Cell Death Discov. 7, 20 (2021).","journal-title":"Cell Death Discov."},{"key":"29017_CR5","doi-asserted-by":"publisher","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","volume":"284","author":"YJ Machida","year":"2009","unstructured":"Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A. & Dutta, A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J. Biol. Chem. 284, 34179\u201334188 (2009).","journal-title":"J. Biol. Chem."},{"key":"29017_CR6","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/MCB.01517-08","volume":"29","author":"S Misaghi","year":"2009","unstructured":"Misaghi, S. et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell Biol. 29, 2181\u20132192 (2009).","journal-title":"Mol. Cell Biol."},{"key":"29017_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41419-018-1206-5","volume":"9","author":"EB Affar","year":"2018","unstructured":"Affar, E. B. & Carbone, M. BAP1 regulates different mechanisms of cell death. Cell Death Dis. 9, 1151 (2018).","journal-title":"Cell Death Dis."},{"key":"29017_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41419-018-0500-6","volume":"9","author":"W Sime","year":"2018","unstructured":"Sime, W. et al. BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. Cell Death Dis. 9, 458 (2018).","journal-title":"Cell Death Dis."},{"key":"29017_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1126\/science.aav4902","volume":"364","author":"M He","year":"2019","unstructured":"He, M. et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science 364, 283\u2013285 (2019).","journal-title":"Science"},{"key":"29017_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20, 1181\u20131192 (2018).","journal-title":"Nat. Cell Biol."},{"key":"29017_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature22798","volume":"546","author":"A Bononi","year":"2017","unstructured":"Bononi, A. et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature 546, 549\u2013553 (2017).","journal-title":"Nature"},{"key":"29017_CR12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/onc.2015.243","volume":"35","author":"A Napolitano","year":"2016","unstructured":"Napolitano, A. et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 35, 1996\u20132002 (2016).","journal-title":"Oncogene"},{"key":"29017_CR13","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","volume":"76","author":"Y Kadariya","year":"2016","unstructured":"Kadariya, Y. et al. Bap1 Is a bona fide tumor suppressor: Genetic evidence from mouse models carrying heterozygous germline Bap1 mutations. Can. Res. 76, 2836\u20132844 (2016).","journal-title":"Can. Res."},{"key":"29017_CR14","doi-asserted-by":"crossref","unstructured":"Xu, J., et al. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma. Cancer Res. (2014).","DOI":"10.1158\/0008-5472.CAN-14-1328"},{"key":"29017_CR15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey, A. et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541\u20131546 (2012).","journal-title":"Science"},{"key":"29017_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu, H. et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl. Acad. Sci. U S A 111, 285\u2013290 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"29017_CR17","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1016\/j.febslet.2013.10.035","volume":"587","author":"ZM Eletr","year":"2013","unstructured":"Eletr, Z. M., Yin, L. & Wilkinson, K. D. BAP1 is phosphorylated at serine 592 in S-phase following DNA damage. FEBS Lett. 587, 3906\u20133911 (2013).","journal-title":"FEBS Lett."},{"key":"29017_CR18","first-page":"1","volume":"1","author":"IH Ismail","year":"2014","unstructured":"Ismail, I. H. et al. Germ-line mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res. 1, 1 (2014).","journal-title":"Cancer Res."},{"key":"29017_CR19","doi-asserted-by":"crossref","unstructured":"Lee, S. A., et al. BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability. Cell Death Differ. (2022).","DOI":"10.1038\/s41418-022-01024-w"},{"key":"29017_CR20","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1038\/ncomms6128","volume":"5","author":"HS Lee","year":"2014","unstructured":"Lee, H. S., Lee, S. A., Hur, S. K., Seo, J. W. & Kwon, J. Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. Nat. Commun. 5, 5128 (2014).","journal-title":"Nat. Commun."},{"key":"29017_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14348\/molcells.2021.2258","volume":"44","author":"HR Seo","year":"2021","unstructured":"Seo, H. R. et al. CHIP and BAP1 act in concert to regulate INO80 ubiquitination and stability for DNA replication. Mol. Cells 44, 101\u2013115 (2021).","journal-title":"Mol. Cells"},{"key":"29017_CR22","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1042\/BCJ20190622","volume":"476","author":"HS Lee","year":"2019","unstructured":"Lee, H. S. et al. BAP1 promotes stalled fork restart and cell survival via INO80 in response to replication stress. Biochem. J. 476, 3053\u20133066 (2019).","journal-title":"Biochem. J."},{"key":"29017_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2015.08.013","volume":"369","author":"J Peng","year":"2015","unstructured":"Peng, J. et al. Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. Cancer Lett. 369, 167\u2013174 (2015).","journal-title":"Cancer Lett."},{"key":"29017_CR24","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"Ventii, K. H. et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68, 6953\u20136962 (2008).","journal-title":"Cancer Res."},{"key":"29017_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2007","unstructured":"Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108\u20131113 (2007).","journal-title":"Science"},{"key":"29017_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman, M. H. et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet. 48, 856\u2013859 (2011).","journal-title":"J. Med. Genet."},{"key":"29017_CR27","doi-asserted-by":"crossref","unstructured":"Bott, M., et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 43, 668\u2013672 (2011).","DOI":"10.1038\/ng.855"},{"key":"29017_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.1014","volume":"44","author":"G Guo","year":"2012","unstructured":"Guo, G. et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat. Genet. 44, 17\u201319 (2012).","journal-title":"Nat. Genet."},{"key":"29017_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010).","journal-title":"Science"},{"key":"29017_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751\u2013759 (2012).","journal-title":"Nat. Genet."},{"key":"29017_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa, J. R. et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022\u20131025 (2011).","journal-title":"Nat. Genet."},{"key":"29017_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","volume":"69","author":"M Carbone","year":"2019","unstructured":"Carbone, M. et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J. Clin. 69, 402\u2013429 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"29017_CR33","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","volume":"74","author":"J Xu","year":"2014","unstructured":"Xu, J. et al. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma. Can. Res. 74, 4388\u20134397 (2014).","journal-title":"Can. Res."},{"key":"29017_CR34","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1038\/ncomms9471","volume":"6","author":"J Qin","year":"2015","unstructured":"Qin, J. et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. Nat. Commun. 6, 8471 (2015).","journal-title":"Nat. Commun."},{"key":"29017_CR35","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1038\/ncomms8307","volume":"6","author":"A Balasubramani","year":"2015","unstructured":"Balasubramani, A. et al. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. Nat. Commun. 6, 7307 (2015).","journal-title":"Nat. Commun."},{"key":"29017_CR36","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1038\/s41467-018-05085-9","volume":"9","author":"S Asada","year":"2018","unstructured":"Asada, S. et al. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nat. Commun. 9, 2733 (2018).","journal-title":"Nat. Commun."},{"key":"29017_CR37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"29017_CR38","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1242\/jcs.03485","volume":"120","author":"K Aoki","year":"2007","unstructured":"Aoki, K. & Taketo, M. M. Adenomatous polyposis coli (APC): A multi-functional tumor suppressor gene. J. Cell Sci. 120, 3327\u20133335 (2007).","journal-title":"J. Cell Sci."},{"key":"29017_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.cellbio.20.012103.094541","volume":"20","author":"IS Nathke","year":"2004","unstructured":"Nathke, I. S. The adenomatous polyposis coli protein: The Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 20, 337\u2013366 (2004).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"29017_CR40","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1021\/bi052135t","volume":"45","author":"A Case","year":"2006","unstructured":"Case, A. & Stein, R. L. Mechanistic studies of ubiquitin C-terminal hydrolase L1. Biochemistry 45, 2443\u20132452 (2006).","journal-title":"Biochemistry"},{"key":"29017_CR41","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1038\/ncomms10292","volume":"7","author":"DD Sahtoe","year":"2016","unstructured":"Sahtoe, D. D., van Dijk, W. J., Ekkebus, R., Ovaa, H. & Sixma, T. K. BAP1\/ASXL1 recruitment and activation for H2A deubiquitination. Nat. Commun. 7, 10292 (2016).","journal-title":"Nat. Commun."},{"key":"29017_CR42","doi-asserted-by":"publisher","first-page":"W374","DOI":"10.1093\/nar\/gky380","volume":"46","author":"Y Xu","year":"2018","unstructured":"Xu, Y. et al. CavityPlus: A web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res. 46, W374\u2013W379 (2018).","journal-title":"Nucleic Acids Res."},{"key":"29017_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fchem.2013.00039","volume":"1","author":"MG Quesne","year":"2013","unstructured":"Quesne, M. G., Ward, R. A. & de Visser, S. P. Cysteine protease inhibition by nitrile-based inhibitors: A computational study. Front. Chem. 1, 39 (2013).","journal-title":"Front. Chem."},{"key":"29017_CR44","doi-asserted-by":"publisher","first-page":"10610","DOI":"10.1021\/ja903292v","volume":"131","author":"N Amara","year":"2009","unstructured":"Amara, N. et al. Covalent inhibition of bacterial quorum sensing. J. Am. Chem. Soc. 131, 10610\u201310619 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"29017_CR45","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.1205073109","volume":"109","author":"DE Ehmann","year":"2012","unstructured":"Ehmann, D. E. et al. Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 109, 11663\u201311668 (2012).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"29017_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.pathol.2017.03.008","volume":"49","author":"J Chui","year":"2017","unstructured":"Chui, J., Singh, A. & Gill, A. J. Loss of BAP1 expression is very rare in breast carcinoma. Pathology 49, 557\u2013560 (2017).","journal-title":"Pathology"},{"key":"29017_CR47","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/1535-7163.MCT-11-0550","volume":"10","author":"AB Bialkowska","year":"2011","unstructured":"Bialkowska, A. B. et al. Identification of small-molecule inhibitors of the colorectal cancer oncogene Kruppel-like factor 5 expression by ultrahigh-throughput screening. Mol. Cancer Ther. 10, 2043\u20132051 (2011).","journal-title":"Mol. Cancer Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29017-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T13:44:01Z","timestamp":1701870241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29017-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29017"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29017-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2264"}}